Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based Chemotherapy

NCT00005836 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Ovarian Cancer
Primary Peritoneal Cavity Cancer

Interventions

DRUG: oxaliplatin

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]